3D-US Construct on Volumetric Assessment of Lung Disease & Clinical Application
Three-dimensional Ultrasonic Construct on Volumetric Assessment of Lung Disease and Its Clinical Application
1 other identifier
observational
300
1 country
1
Brief Summary
The goal of this observational study is to establish the three-dimensional construct of lung lesion via ultrasound in patients with peripheral lung lesions or any superficial lesion in thoracic fields. The primary question our study aims to answer is: Whether the 3D ultrasound morphology can reflect lung disease entities? Whether the 3D volumetric follow-up protocol can be standardised to reflect lung disease status?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2026
CompletedFirst Posted
Study publicly available on registry
May 7, 2026
CompletedStudy Start
First participant enrolled
May 30, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2031
Study Completion
Last participant's last visit for all outcomes
February 28, 2031
May 7, 2026
May 1, 2026
4.8 years
May 3, 2026
May 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
volume of measured lesion
Standard volume will be defined by computed tomography measurement, and the ultrasound 3D-volmetric result would be compared
from enrollment, every 6 weeks until 24th week
Study Arms (1)
ultrasound work-up
participants with peripheral lesions, not confined to lung, referred for ultrasound workup
Eligibility Criteria
Participants with peripheral lung lesions or with lesions located at superficial thoracic field will be recruited from referral cases for ultrasound workup
You may qualify if:
- Participants suspect with lung lesions referred for ultrasound workup
You may not qualify if:
- Participants aged \< 18 years
- Participants refusal
- Participants with implanted metal in scanning area interfering data collection
- Participants who cannot perform breath holding for at least 1 second
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
YEN-LIN CHEN, Doctor of Medicine
National Taiwan University Hospital
Central Study Contacts
YAO-WEN KUO, Ph.D
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 3, 2026
First Posted
May 7, 2026
Study Start (Estimated)
May 30, 2026
Primary Completion (Estimated)
February 28, 2031
Study Completion (Estimated)
February 28, 2031
Last Updated
May 7, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual data may contain images with unremovable personal information, which may violate the Personal Data Protection Act.